Article Details
Retrieved on: 2024-01-03 22:42:27
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
03, 2024 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of ...
Article found on: menafn.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here